Very proud to be selected in the top 10 EMEUNET abstracts at #EULAR2020 !

Niemantsverdriet (OP0113): lower expression of IFN-γ, PHEX, IGF-1, IL7R, CD19, or CCR7 in #arthralgia was associated with #arthritis development. IGF-1 and IL7R showed independent, added value. ❓underlying pathogenic mechanisms for the 'second hit' of #arthritis? #EULAR2020 JRC

Niemantsverdriet (OP0222): visiting a rheumatologist within 6-weeks of symptoms is associated with sustained #remission but not with radiographic progression in #LeidenEAC and #ESPOIR cohorts. #EULAR2020 #EULAR2020goesvirtual JRC

#EULAR2020 OP0235 achieving holy grail of sustained disease free remission for min 1yr after treatment stopped in early RA. More likely for ACPA neg pts with prompt profound drop DAS by month 4. If achieve this may help decision to stop csDMARD.

Super proud of my brilliant wife!

Great presentation Linda Nab 📏! And also very fun!

My new article is online! We studied long-term outcomes in a longstanding cohort of RA-patients and concluded that RA consists of 2 subsets that responded differently to treatment improvements. Very proud! doi.org/10.1371/journa… #rheumatology #RheumTwitter PLOS Medicine

Last paper of my PhD was just published. Here we describe the absence of association between MRI-inflammation and fatigue in a longitudinal RA cohort. Very happy!

New findings into #rheumatoid #arthrits development: ▶️HLA-SE and smoking act at different stages 🚬smoking confers risk for ACPA and symptom development 🧬HLA-SE mediates symptom and IA development 🔗ard.bmj.com/content/early/…

My husband just came up with a podcast idea: academic spouses talk about what they think their partners’ work is about. 🤣

Last week I successfully defended my thesis! I had a great day, thanks to my promotors, paranymphs and opposition committee. Are you interested in my thesis? You can read it at books.gildeprint.nl/thesis/577387-…

Very proud!

Proud to share our most recent publication in @ARD_BMJ 👉age at onset of #RA could not be explained by differences in patients (eg genes), but almost fully by socioeconomic factors (ie environment) of the countries people were living in. pubmed.ncbi.nlm.nih.gov/37230737/ Alexandre Sepriano